These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1820983)

  • 1. Clotting abnormalities in children during maintenance chemotherapy for acute lymphoblastic leukemia.
    Aricò M; Gamba G; Raiteri E; Montani N; De Amici M; Burgio GR
    Haematologica; 1991; 76(6):472-4. PubMed ID: 1820983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose methotrexate administration and acute liver damage in children treated for acute lymphoblastic leukemia. A prospective study.
    Locasciulli A; Mura R; Fraschini D; Gornati G; Scovena E; Gervasoni A; Uderzo C; Masera G
    Haematologica; 1992; 77(1):49-53. PubMed ID: 1398282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute lymphoblastic leukemia: dental health of children in maintenance therapy.
    Sepet E; Aytepe Z; Ozerkan AG; Yalman N; Guven Y; Anak S; Devecioglu O; Agaoglu L; Gedikoglu G
    J Clin Pediatr Dent; 1998; 22(3):257-60. PubMed ID: 9641104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance chemotherapy of acute lymphoblastic leukemia in children.
    Schmiegelow K
    Dan Med Bull; 1998 Nov; 45(5):510-32. PubMed ID: 9850812
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy plays a major role in the inhibition of catch-up growth during maintenance therapy for childhood acute lymphoblastic leukemia.
    Groot-Loonen JJ; Otten BJ; van t' Hof MA; Lippens RJ; Stoelinga GB
    Pediatrics; 1995 Oct; 96(4 Pt 1):693-5. PubMed ID: 7567332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of high-dose methotrexate on the hemostatic system in childhood acute lymphoblastic leukemia.
    Totan M; Dagdemir A; Ak AR; Albayrak D; Kucukoduk S
    Med Pediatr Oncol; 2001 Apr; 36(4):429-33. PubMed ID: 11260565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
    Lange BJ; Blatt J; Sather HN; Meadows AT
    Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia.
    Halonen P; Salo MK; Mäkipernaa A
    J Pediatr; 2001 Mar; 138(3):428-31. PubMed ID: 11241057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
    Mejía-Arangure JM; Fajardo-Gutíerrez A; Bernáldez-Ríos R; Rodríguez-Zepeda MC; Espinoza-Hernández L; Martínez-García MC
    Arch Med Res; 1997; 28(2):273-9. PubMed ID: 9204621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of prognostic factors on the course of acute lymphoblastic leukemia in children].
    Rokicka-Milewska R; Derulska D; Lewicki Z
    Pediatr Pol; 1988 Nov; 63(11):703-15. PubMed ID: 3253657
    [No Abstract]   [Full Text] [Related]  

  • 11. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Sancho JM; Ribera JM; Xicoy B; Morgades M; Oriol A; Tormo M; del Potro E; Debén G; Abella E; Bethencourt C; Ortín X; Brunet S; Ortega-Rivas F; Novo A; López R; Hernández-Rivas JM; Sanz MA; Feliu E;
    Eur J Haematol; 2007 Feb; 78(2):102-10. PubMed ID: 17087744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recurrences after completion of the treatment of acute lymphoblastic leukemia in children].
    Ochocka M; Matysiak M; Newecka-Samól T; Kulus M; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Jackowska T; Jakowicka M
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):350-3. PubMed ID: 1437752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
    Rivera-Luna R; Cardenas-Cardos R; Leal-Leal C; Navarro-Alegría I; Meza-Coria C; Gómez-Martínez R; Vega-Vega L
    Arch Med Res; 1997; 28(2):233-9. PubMed ID: 9204615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
    Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
    Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M
    Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
    Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
    Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preliminary evaluation of the treatment of recurrences of acute lymphoblastic leukemia by the BFM (Henze) method].
    Ochocka M; Zelenay E
    Pediatr Pol; 1988 Nov; 63(11):716-22. PubMed ID: 3253658
    [No Abstract]   [Full Text] [Related]  

  • 20. Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991.
    Mauger DC; Skeen JE
    N Z Med J; 1998 Nov; 111(1078):454-6. PubMed ID: 9891565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.